- Opening price: USD 75.03 (NASDAQ)
- Trading period: 24‑hour window ending 07:18 AM Central Europe, Friday 23 Oct 2026
- Daily movement: Down 4.38 %
Key Metrics
| Item | Value |
|---|
| Current market capitalization | USD 2.9 billion |
| Shares outstanding | 38.4 million |
| 24‑hour volume | USD 352.6 million |
| 200‑day simple moving average | USD 70.65 |
| 52‑week high | USD 99.50 (08 Dec 2025) |
| 52‑week low | USD 40.00 (13 Feb 2026) |
- Month‑over‑month change: Up 10.98 %
| Ticker | Company | 24‑hour change | Current price | Market cap | P/E (where available) |
|---|
| LMND | Lemonade | -0.26 % | USD 45.41 | USD 3.5 bn | – |
| CAR | Avis Budget | +3.21 % | USD 101.55 | USD 3.5 bn | – |
| INTA | Intapp | +1.23 % | USD 47.18 | USD 3.5 bn | – |
| ACAD | Acadia | +0.59 % | USD 20.31 | USD 3.5 bn | 9.13 |
| LQDA | Liquidia | 0.00 % | USD 39.69 | USD 3.5 bn | 28.04 |
Company Overview
Disc Medicine, Inc. is a clinical‑stage biopharmaceutical firm headquartered in Watertown, United States. The company focuses on discovering, developing, and commercializing novel therapies for patients with serious hematologic diseases. Its research targets fundamental biological pathways involved in red blood cell biology to address a broad spectrum of hematological disorders. The company’s shares trade on the Nasdaq under the ticker IRON. The corporate website is www.discmedicine.com
.
